Click here to go to the previous page
Continuous Glucose Monitoring & its Role in Diabetes Management
Program Code:
M41
Date:
Tuesday, June 7, 2011
Time:
8:30 AM to 9:15 AM
EST
SPEAKER
:
Dace Lilliana Trence, FACE,MD, Univ of Washington Med Ctr
Disclosures: DLT: Stock Owner, Medtronic Minimed; Principal Investigator, Novo Nordisk.